Citations

Mayo Clinic

Showing 10 of 108602 citations.

Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions
Major, Ajay , Yu, Jovian , Shukla, Navika , Karrison, Theodore , Treitman, Rachel, Haverkos, Bradley M. , Godfrey, James , Babcook, Melissa A., Voorhees, Timothy , Carlson, Sophie G. , Gaut, Daria , Oliai, Caspian , Winter, Allison , Hill, Brian T. , Bansal, Radhika , Nizamuddin, Imran , Fitzgerald, Lindsey , Stephens, Deborah M. , Hu, Marie , Bachanová, Veronika , Slade, Michael , Singh, Nathan , Bishop, Michael R. , Riedell, Peter A. , Haverkos, Bradley M , Voorhees, Timothy J , Romancik, Jason T , Bansal, Radhika , Villasboas, Jose Caetano , Karmali, Reem , Stephens, Deborah M , Pophali, Priyanka , Trabolsi, Asaad , Schatz, Jonathan H , Hu, Marie , Slade, Michael J , Singh, Nathan , Ahmed, Nausheen , McGuirk, Joseph , Riedell, Peter A , Bachanova, Veronika , Major, Ajay , Che, Yan, Kamdar, Manali , Oliai, Caspian H , Romancik, Jason T. , Villasboas, José C. , Karmali, Reem , Pophali, Priyanka A. , Ahmed, Nausheen , McGuirk, Joseph P. , Bishop, Michael Russell , Kline, Justin Paul

Blood Advances | April 7, 2023 | Volume: 7 | Issue: 16 | Pages: 4528-4538

10.1182/bloodadvances.2023010016 | PMID 37026796 Get It

AbstractCheckpoint inhibitor (CPI) therapy with anti–PD-1 antibodies has been associated with mixed outcomes in small cohorts of patients with relapsed aggressive B-cell lymphomas after CAR-T failure. To define CPI therapy efficacy more definitively in this population, we retrospectively evaluated clinical outcomes in a large cohort of 96 patients with aggressive B-cell lymphomas receiving CPI therapy after CAR-T failure across 15 US academic centers. Most patients (53%) had diffuse large B-cell lymphoma, were treated with axicabtagene ciloleucel (53%), relapsed early (≤180 days) after CAR-T (83%), and received pembrolizumab (49%) or nivolumab (43%). CPI therapy was associated with an overall response rate of 19% and a complete response rate of 10%. Median duration of response was 221 days. Median progression-free survival (PFS) and overall survival (OS) were 54 and 159 days, respectively. Outcomes to CPI therapy were significantly improved in patients with primary mediastinal B-cell lymphoma. PFS (128 vs 51 days) and OS (387 vs 131 days) were significantly longer in patients with late (>180 days) vs early (≤180 days) relapse after CAR-T. Grade ≥3 adverse events occurred in 19% of patients treated with CPI. Most patients (83%) died, commonly because of progressive disease. Only 5% had durable responses to CPI therapy. In the largest cohort of patients with aggressive B-cell lymphoma treated with CPI therapy after CAR-T relapse, our results reveal poor outcomes, particularly among those relapsing early after CAR-T. In conclusion, CPI therapy is not an effective salvage strategy for most patients after CAR-T, where alternative approaches are needed to improve post–CAR-T outcomes.
Multiple abnormal peripheral blood gene expression assay results are correlated with subsequent graft loss after kidney transplantation
Heilman, Raymond L. , Mai, Martin, Smith, Byron H. , Park, Walter D. , Holman, John , Stegall, Mark D. , Smith, Byron , Park, Walter , Holman, John , Stegall, Mark D , Fleming, James N

Clinical Transplantation | April 7, 2023 | Volume: 37 | Issue: 8 | Pages: No page available

10.1111/ctr.14987 | PMID 37026820 Get It

AbstractBackgroundThe aim of this study was to correlate peripheral blood gene expression profile (GEP) results during the first post‐transplant year with outcomes after kidney transplantation.MethodsWe conducted a prospective, multicenter observational study of obtaining peripheral blood at five timepoints during the first post‐transplant year to perform a GEP assay. The cohort was stratified based on the pattern of the peripheral blood GEP results: Tx‐all GEP results normal, 1 Not‐TX had one GEP result abnormal and >1 Not‐TX two or more abnormal GEP results. We correlated the GEP results with outcomes after transplantation.ResultsWe enrolled 240 kidney transplant recipients. The cohort was stratified into the three groups: TX n = 117 (47%), 1 Not‐TX n = 59 (25%) and >1 Not‐TX n = 64 (27%). Compared to the TX group, the >1 Not‐TX group had lower eGFR (p < .001) and more chronic changes on 1‐year surveillance biopsy (p = .007). Death censored graft survival showed inferior graft survival in the >1 Not‐TX group (p < .001) but not in the 1 Not‐TX group. All graft losses in the >1 Not‐TX group occurred after 1‐year post‐transplant.ConclusionsWe conclude that a pattern of persistently Not‐TX GEP assay correlates with inferior graft survival.
Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients With Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 Study
Tyson, Mark D. , Palou, Juan, Rodríguez, Óscar , Mir, Maria Carmen , Dickstein, Rian J., Guerrero‐Ramos, Félix , Scarpato, Kristen R., Messing, Edward M. , Cutie, Christopher J., Maffeo, John, Raybold, Bradley, Chau, Albert, Stromberg, Katharine A., Keegan, Kirk A., Morris, David S. , Palou, Joan, Hafron, Jason M. , Chau, Albert, Stromberg, Katharine

Journal of Urology | April 7, 2023 | Volume: 209 | Issue: 5 | Pages: 890-900

10.1097/ju.0000000000003195 | PMID 37026631 Get It

Provisional practice recommendation for the management of myopathy in VCP‐associated multisystem proteinopathy
Roy, Bhaskar , Peck, Allison , Evangelista, Teresinha , Díaz‐Manera, Jordi , Korb, Manisha Kak , Wicklund, Matthew , Milone, Margherita , Freimer, Miriam , Kushlaf, Hani , Villar‐Quiles, Rocío‐Nur , Stojkovic, Tanya , Needham, Merrilee , Palmio, Johanna , Keung, Benison , Mozaffar, Tahseen , Weihl, Conrad C. , Kimonis, Virginia , Milone, M , Díaz-Manera, Jordi , Pfeffer, Gerald , Wang, Leo L. , Lloyd, Thomas E , Roy, Bhaskar

Annals of Clinical and Translational Neurology | April 7, 2023 | Volume: 10 | Issue: 5 | Pages: 686-695

10.1002/acn3.51760 | PMID 37026610 Get It

AbstractValosin‐containing protein (VCP)‐associated multisystem proteinopathy (MSP) is a rare genetic disorder with abnormalities in the autophagy pathway leading to various combinations of myopathy, bone diseases, and neurodegeneration. Ninety percent of patients with VCP‐associated MSP have myopathy, but there is no consensus‐based guideline. The goal of this working group was to develop a best practice set of provisional recommendations for VCP myopathy which can be easily implemented across the globe. As an initiative by Cure VCP Disease Inc., a patient advocacy organization, an online survey was initially conducted to identify the practice gaps in VCP myopathy. All prior published literature on VCP myopathy was reviewed to better understand the different aspects of management of VCP myopathy, and several working group sessions were conducted involving international experts to develop this provisional recommendation. VCP myopathy has a heterogeneous clinical phenotype and should be considered in patients with limb‐girdle muscular dystrophy phenotype, or any myopathy with an autosomal dominant pattern of inheritance. Genetic testing is the only definitive way to diagnose VCP myopathy, and single‐variant testing in the case of a known familial VCP variant, or multi‐gene panel sequencing in undifferentiated cases can be considered. Muscle biopsy is important in cases of diagnostic uncertainty or lack of a definitive pathogenic genetic variant since rimmed vacuoles (present in ~40% cases) are considered a hallmark of VCP myopathy. Electrodiagnostic studies and magnetic resonance imaging can also help rule out disease mimics. Standardized management of VCP myopathy will optimize patient care and help future research initiatives.
Mortality and Major Adverse Cardiac Events in Patients With Breast Cancer Receiving Radiotherapy: The First Decade
Jacobs, J. , L’Hoyes, Wouter , Lauwens, Lieselotte , Yu, Yu‐Ling , Brusselmans, Marius , Weltens, Caroline , Voigt, Jens‐Uwe , Wildiers, Hans , Neven, Patrick , Herrmann, Joerg , Janssens, Stefan , Aelst, Lucas Van , Jacobs, Johanna E J , Thijs, Lutgarde , Staessen, Jan A , Janssens, Stefan , Van Aelst, Lucas N L , Voigt, Jens-Uwe , Wildiers, Hans

Journal of the American Heart Association | April 7, 2023 | Volume: 12 | Issue: 8 | Pages: No page available

10.1161/jaha.122.027855 | PMID 37026536 Get It

Background Treatment for breast cancer (BC) frequently involves radiotherapy. Guidelines recommend screening for cardiac adverse events starting 10 years after radiotherapy. The rationale for this interval is unclear. Methods and Results We aimed to study cardiovascular event rates in the first decade following curative radiotherapy for BC. We compared mortality and cardiovascular event rates with an age‐ and risk factor‐matched control population. We included 1095 patients with BC (mean age 56±12 years). Two hundred and eighteen (19.9%) women died. Cancer and cardiovascular mortality caused 107 (49.1%) and 22 (10.1%) deaths, respectively. A total of 904 cases were matched to female FLEMENGHO (Flemish Study on Environment, Genes and Health Outcomes) participants. Coronary artery disease incidence was similar (risk ratio [RR], 0.75 [95% CI, 0.48–1.18]), yet heart failure (RR, 1.97 [95% CI, 1.19–3.25]) and atrial fibrillation/flutter (RR, 1.82 [95% CI, 1.07–3.08]) occurred more often in patients with BC. Age (hazard ratio [HR], 1.033 [95% CI, 1.006–1.061], P =0.016), tumor grade (HR, 1.739 [95% CI, 1.166–2.591], P =0.007), and neoadjuvant treatment setting (HR, 2.782 [95% CI, 1.304–5.936], P =0.008) were risk factors for mortality. Risk factors for major adverse cardiac events were age (HR, 1.053 [95% CI, 1.013–1.093]; P =0.008), mean heart dose (HR, 1.093 [95% CI, 1.025–1.167]; P =0.007), history of cardiovascular disease (HR, 2.386 [95% CI, 1.096–6.197]; P =0.029) and Mayo Clinic Cardiotoxicity Risk Score (HR, 2.664 [95% CI, 1.625–4.367]; P <0.001). Conclusions Ten‐year mortality following curative treatment for unilateral BC was mainly cancer related, but heart failure and atrial fibrillation/flutter were already common in the first decade following irradiation. Mean heart dose, pre‐existing cardiovascular diseases, and Mayo Clinic Cardiotoxicity Risk Score were risk factors for cardiac adverse events. These results suggest a need for early dedicated cardio‐oncological follow‐up after radiotherapy.
The association between bone mineral density and proximal junctional kyphosis in adult spinal deformity: a systematic review and meta-analysis
McCandless, Martin G. , Bhandarkar, Archis R. , Lakomkin, Nikita , Mikula, Anthony L. , Michalopoulos, Giorgos D. , Bydon, Mohamad , Flanigan, Patrick M, Michalopoulos, Giorgos , Chen, Jeffrey , Flanigan, Patrick Michael

Journal of Neurosurgery: Spine | April 7, 2023 | Volume: 39 | Issue: 1 | Pages: 82-91

10.3171/2023.2.spine221101 | PMID 37029673 Get It

OBJECTIVE Proximal junctional kyphosis (PJK) is a complication of surgical management for adult spinal deformity (ASD) with a multifactorial etiology. Many risk factors are controversial, and their relative importance is not fully understood. The authors aimed to elucidate the association between bone mineral density (BMD) and PJK. METHODS A systematic literature search was performed using PubMed and Web of Science keywords of "Proximal Junctional Kyphosis [MeSH] OR Proximal Junctional Failure [MeSH]" AND "Bone Mineral Density [MeSH] OR Hounsfield Units [MeSH] OR DEXA [MeSH]" set to the date range of January 2002 to July 2022. Studies required a minimum of 10 patients and 12 months of follow-up. Articles were included if they were in the English language and presented a primary retrospective cohort that included a comparison of patients with and without PJK, as well as a radiographic biomarker for BMD, such as Hounsfield units (HU) or T-score. RESULTS A total of 18 unique studies with 2185 patients who underwent ASD surgery were identified. Of these, 537 patients (24.6%) developed PJK. Eight studies provided T-scores that were amenable to comparison, which found that patients who developed PJK were found to have lower BMD T-scores by a mean of −0.69 (95% CI −0.88 to −0.50; I 2 = 63.9%, p < 0.001). The HU at the UIV among patients with the PJK group (n = 101) compared with the non-PJK group (n = 156) was found to be significantly lower (mean difference −32.35, 95% CI −46.05 to −18.65; I 2 = 28.7%, p < 0.001). CONCLUSIONS This meta-analysis suggests that low preoperative BMD as measured by T-score and a diagnosis of osteoporosis were associated with higher postoperative PJK. Additionally, lower HU on CT at the UIV were found to be significant risk factors for postoperative PJK as well. These findings suggest that more attention to preoperative BMD is a risk factor for PJK among ASD patients is warranted.
Efficient reconstruction of cell lineage trees for cell ancestry and cancer
Jang, Yeongjun , Fasching, Liana , Tomasini, Livia , Schreiner, Jeremy D. , Szekely, Anna , Fernandez, Thomas , Vaccarino, Flora M. , Abyzov, Alexej , Vaccarino, Flora M , Abyzov, Alexej , Fernandez, Thomas V , Jang, Yeongjun , Bae, Taejeong , Leckman, James F.

Nucleic Acids Research | April 7, 2023 | Volume: 51 | Issue: 10 | Pages: e57-e57

10.1093/nar/gkad254 | PMID 37026484 Get It

Abstract Mosaic mutations can be used to track cell ancestries and reconstruct high-resolution lineage trees during cancer progression and during development, starting from the first cell divisions of the zygote. However, this approach requires sampling and analyzing the genomes of multiple cells, which can be redundant in lineage representation, limiting the scalability of the approach. We describe a strategy for cost- and time-efficient lineage reconstruction using clonal induced pluripotent stem cell lines from human skin fibroblasts. The approach leverages shallow sequencing coverage to assess the clonality of the lines, clusters redundant lines and sums their coverage to accurately discover mutations in the corresponding lineages. Only a fraction of lines needs to be sequenced to high coverage. We demonstrate the effectiveness of this approach for reconstructing lineage trees during development and in hematologic malignancies. We discuss and propose an optimal experimental design for reconstructing lineage trees.
Internal Fixation of Unstable Osteochondritis Dissecans of the Knee: Long-term Outcomes in Skeletally Immature and Mature Patients
Husen, Martin , Weiden, Goran S. van der , Poudel, Keshav , Krych, Aaron J. , Saris, Daniël B.F. , Krych, Aaron J , Custers, Roel J.H. , Stuart, Michael J.

The American Journal of Sports Medicine | April 7, 2023 | Volume: 51 | Issue: 6 | Pages: 1403-1413

10.1177/03635465231164410 | PMID 37026762 Get It

Background: Osteochondritis dissecans (OCD) is a disorder originating in the subchondral bone, leading to focal lesions with risk of fragmentation and secondary damage of the articular cartilage. It remains controversial if surgical treatment of such lesions is equally successful in skeletally immature and mature patients. Purpose: To determine (1) the long-term clinical success rate after internal fixation of unstable OCD in skeletally immature and mature patients based on physeal status, (2) if patient-specific and procedural variables influence the risk of failure, and (3) patient-reported outcome measures over time. Study Design: Cohort study; Level of evidence, 3. Methods: A multicenter retrospective cohort study was conducted investigating skeletally immature and mature patients treated for unstable OCD lesions of the knee between 2000 and 2015. The healing rate was assessed by radiological imaging and clinical follow-up. Failure was defined as any definitive reoperation for the initially treated OCD lesion. Results: A total of 81 patients met inclusion criteria, including 25 skeletally immature patients and 56 patients with closed physes at the time of surgery. After a mean follow-up time of 11.3 ± 4 years, 58 (71.6%) patients had healed lesions, whereas the lesions failed to heal in 23 (28.4%) patients. No significant difference in risk of failure was observed based on physeal maturation status (hazard ratio, 0.78; 95% CI, 0.33-1.84; P = .56). Lateral versus medial condylar lesion location conferred an increased risk of failure ( P < .05) for both skeletally immature and mature patients. Multivariate analysis of skeletal maturity status showed that a lateral femoral condylar location was an independent risk factor for failure (hazard ratio, 0.22; 95% CI, 0.1-0.5; P < .05). The mean patient-reported outcome scores (International Knee Documentation Committee [IKDC] score and Knee injury and Osteoarthritis Outcome Score [KOOS]) increased significantly after surgery and remained high at the final follow-up ( P < .05). The final scores (mean ± SD) at a mean follow-up of 135.8 months (range, 80-249 months) were IKDC, 86.6 ± 16.7; KOOS Pain, 88.7 ± 18.1; KOOS Symptoms, 89.3 ± 12.6; KOOS Activities of Daily Living, 89.3 ± 21.6; KOOS Sport and Recreation, 79.8 ± 26.3; and KOOS Quality of Life, 76.7 ± 26.3. Conclusion: The long-term results after internal fixation of OCD fragments show high rates of healing and sustainable subjective improvement of knee function and quality of life. A healing rate of 72% was noted at a mean follow-up of 11.3 years. The stage of skeletal maturity had no significant influence on the rate of failure. Lateral femoral condylar lesion location is an independent risk factor for failure in skeletally mature and immature patients.
Outcomes of Open Versus Arthroscopic Treatment of HAGL Tears
Lee, Simon , Krych, Aaron J. , Peebles, Annalise M., Dekker, Travis J. , Arner, Justin W. , Whalen, Ryan J. , Provencher, Matthew T. , Ernat, Justin J , Whalen, Ryan J , Krych, Aaron J , Rider, Danielle E.

The American Journal of Sports Medicine | April 7, 2023 | Volume: 51 | Issue: 6 | Pages: 1581-1587

10.1177/03635465231164141 | PMID 37026744 Get It

Background: Lesions that involve humeral avulsions of the glenohumeral ligament (HAGLs), although less common, are primary contributors to recurrent events of dislocation and subluxation of the glenohumeral joint. Purpose: To describe the clinical presentation, examination, and surgical outcomes of patients presenting with HAGL lesions who underwent repair using an arthroscopic or open technique. Study Design: Cohort study; Level of evidence, 3. Methods: A multicenter retrospective review of prospectively collected data was performed of skeletally mature patients without glenohumeral arthritis who presented with HAGL lesions and subsequently underwent arthroscopic or open repair between 2005 and 2017. Independent variables included patient characteristics, clinical presentation, physical examination findings, and arthroscopic findings. Dependent variables included pre- and postoperative Single Assessment Numeric Evaluation (SANE) score, Western Ontario Shoulder Instability Index (WOSI) score, and range of motion outcomes. Results: Eighteen patients diagnosed with a HAGL lesion who underwent primary arthroscopic repair (n = 7) or open repair (n = 11) were included. There were 17 male patients and 1 female patient with a mean age of 24.9 years (range, 16-38 years). Mean follow-up duration was 50.9 months (range, 24-160 months). Seventeen patients (94.4%) reported pain as the most common symptom, and 7 (38.9%) reported sensation of instability. Scores significantly improved from pre- to postoperative for the arthroscopic and open groups ( P < .001): SANE (mean ± SD; arthroscopic, 30.7 ± 15.7 to 92.1 ± 12.2; open, 45.5 ± 8.50 to 90.7 ± 5.24) and WOSI (arthroscopic, 51.4 ± 11.4 to 2.49 ± 3.70; open, 45.5 ± 7.37 to 11.5 ± 5.76). The magnitude of improvement in SANE scores was significantly higher for patients treated arthroscopically (Δ60.0; open, Δ46.5; P = .012). Postoperative WOSI scores were also significantly better in the arthroscopic cohort (2.49 ± 3.70; open, 11.5 ± 5.76; P = .00094). Conclusion: Symptomatic HAGL tears present primarily with pain as opposed to instability, necessitating a high index of suspicion for injury. The tears may be treated successfully with an arthroscopic or open technique with significant improvements in patient-reported outcomes and stability.